Korbie, D., Stirzaker, C., Gluz, O., Eulenburg, C. z., Nitz, U., Christgen, M., . . . Harbeck, N. Immunomodulatory gene networks predict treatment response and survival to de-escalated, anthracycline-free neoadjuvant chemotherapy in triple-negative breast cancer in the WSG-ADAPT-TN trial. BMC.
Chicago Style (17th ed.) CitationKorbie, Darren, et al. Immunomodulatory Gene Networks Predict Treatment Response and Survival to De-escalated, Anthracycline-free Neoadjuvant Chemotherapy in Triple-negative Breast Cancer in the WSG-ADAPT-TN Trial. BMC.
MLA (9th ed.) CitationKorbie, Darren, et al. Immunomodulatory Gene Networks Predict Treatment Response and Survival to De-escalated, Anthracycline-free Neoadjuvant Chemotherapy in Triple-negative Breast Cancer in the WSG-ADAPT-TN Trial. BMC.